Verseon Corp (LON:VSN) insider Fodor,Eniko acquired 6,000 shares of the stock in a transaction that occurred on Wednesday, September 21st. The stock was acquired at an average cost of GBX 161 ($2.10) per share, for a total transaction of £9,660 ($12,609.32).

Verseon Corp (LON:VSN) opened at 156.00 on Wednesday. Verseon Corp has a 52-week low of GBX 148.00 and a 52-week high of GBX 230.00. The company’s market capitalization is GBX 236.16 million. The company has a 50-day moving average price of GBX 161.00 and a 200 day moving average price of GBX 163.16.

This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at

Verseon Corp Company Profile

Verseon Corporation is a pharmaceutical company. Its platform is capable of modeling interactions between a protein and a drug molecule with precision sufficient for designing drug candidates. The Company operates through pharmaceutical research segment. The Company uses its drug discovery technology to develop a portfolio of programs targeting disease areas consisting of anti-coagulation, diabetic macular edema (DMA) and oncology.

Receive News & Ratings for Verseon Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verseon Corp and related companies with's FREE daily email newsletter.